Andreas Rummelt Net Worth & Insider Trades

Andreas Rummelt - Director, Alexion Pharmaceuticals, Inc

As of July 23, 2021

What is Andreas Rummelt's Net Worth?

The current estimated net worth of Alexion Pharmaceuticals, Inc's Director, Andreas Rummelt, is estimated to be about $4M . Andreas Rummelt owns about 12,786 units of Alexion Pharmaceuticals, Inc common stock. In the last 11 years at Alexion Pharmaceuticals, Inc, Andreas Rummelt has sold an estimated value of $4M worth.

What is Andreas Rummelt's Past Insider Trading?

Andreas Rummelt's largest purchase order was 9,015 units , worth over $263.57K on October 25, 2011. Andreas Rummelt's largest sale order was 10,000 units , worth over $1.07M on July 31, 2012. In total, Andreas Rummelt has made about 25 transactions over 11 years of their time at Alexion Pharmaceuticals, Inc. Andreas Rummelt usually trades in May, with the busiest year in 2012. The most recent transaction was a sale order of 5,052 units , worth over $861.52K on August 27, 2014.

Andreas Rummelt

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Andreas Rummelt's' Mailing Address?

  • Mailing address is C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

What are Alexion Pharmaceuticals, Inc's Past Insider Trades?

Alexion Pharmaceuticals, Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals, Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO .

ALEXION PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1